Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A David Buchen


  • Svp, Chief Legal Officer at Amneal Pharmaceuticals Inc. (AMRX), 2019-01-07
  • See Remarks at Actavis Plc (ACT), 2015-03-09
  • Chief Legal Officer-Global&sec at Actavis Inc. (ACT), 2013-10-03
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACT $159.30 30,000 Officer 59,966 2013-11-11 Filing
ACT $135.56 10,000 Officer 97,373 2013-08-29 Filing
ACT $133.01 16,800 Officer 97,373 2013-08-12 Filing
ACT $135.00 200 Officer 114,173 2013-08-09 Filing
ACT $89.00 8,000 Officer 98,306 2013-03-12 Filing